Atlas Trials

Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study

Clinical trial NCT02974387 · UNKNOWN

Trial details

NCT number
NCT02974387
Sponsor
Dr Salouti Eye Research Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Must be PRK Candidate
Start date
2017-04-01
Primary completion
2017-08-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.